Reuters logo
BRIEF-Agios says cash, marketable securities were $573.6 mln as of Dec. 31
February 16, 2017 / 12:15 PM / 10 months ago

BRIEF-Agios says cash, marketable securities were $573.6 mln as of Dec. 31

Feb 16 (Reuters) - Agios Pharmaceuticals Inc

* Agios reports fourth quarter and full year 2016 financial results and highlights key 2017 milestones

* Agios Pharmaceuticals Inc - Cash, cash equivalents and marketable securities as of December 31, 2016 were $573.6 million

* Agios Pharma- Expects existing cash, cash equivalents to fund anticipated operating expenses, capital expenditure requirements through at least end of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below